The Pepsi Bottling Group, Inc. - Financial and Strategic Analysis Review

The Pepsi Bottling Group, Inc. - Financial and Strategic Analysis Review


December 31, 2009
25 Pages - SKU: GMD2534948
License type:
Online Download      US $125.00
Global Site License      US $375.00
The Pepsi Bottling Group, Inc. - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “The Pepsi Bottling Group, Inc. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of The Pepsi Bottling Group, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

The Pepsi Bottling Group, Inc. (PBG) is one of the world’s largest beverages manufacturing company. The company is engaged in the manufacturing, selling and distributing of Pepsi-Cola beverages. PBG is a wholly owned subsidiary of PepsiCo, Inc. The company also has the right to produce, sell and distribute soft drink products of companies other than PepsiCo, such as Dr Pepper, Crush and Squirt. It produces broad range of carbonated soft drinks, and other ready-to-drink beverages which include non-carbonated beverages such as Aquafina, Aqua Minerale and Electropura across the US, Mexico, Canada, Spain, Russia, Greece and Turkey. PBG is headquartered at New York, the US.

Recent Developments

Nov 03, 2009: Pepsi Cola Bottling Introduces Drank To New York
Oct 06, 2009: Pepsi Bottling Group Q3 Net Revenues decline
Sep 22, 2009: Pepsi Bottling Group Enters Into Distribution Agreement With O.N.E.

Scope
  • Provides key company information for business intelligence needs
  • The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
  • A quick “one-stop-shop” to understand the company.
  • Enhance business/sales activities by understanding customers’ businesses better.
  • Get detailed information and financial & strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitors’ weaknesses and target the market opportunities available to them.
  • Compare your company’s financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.



More P - Companies reports by Global Markets Direct

PDC Biotech GmbH - Product Pipeline Review - 2014 by Global Markets Direct
PDC Biotech GmbH - Product Pipeline Review - 2014SummaryGlobal Markets Direct’s, ‘PDC Biotech GmbH - Product Pipeline Review - 2014’, provides an overview of the ...
Pluristem Therapeutics Inc. - Product Pipeline Review - 2014 by Global Markets Direct
Pluristem Therapeutics Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Direct’s, ‘Pluristem Therapeutics Inc. - Product Pipeline Review - 2014’, provides an overview of the ...
Pulmatrix, Inc. - Product Pipeline Review - 2013 by Global Markets Direct
Pulmatrix, Inc. - Product Pipeline Review - 2013SummaryGlobal Market Direct’s pharmaceuticals report, “Pulmatrix, Inc. - Product Pipeline Review - 2013” provides data on the Pulmatrix, ...
PsychoGenics, Inc. - Product Pipeline Review - 2013 by Global Markets Direct
PsychoGenics, Inc. - Product Pipeline Review - 2013SummaryGlobal Market Direct’s pharmaceuticals report, “PsychoGenics, Inc. - Product Pipeline Review - 2013” provides data on the PsychoGenics, ...
See all reports like this >>

 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!